AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 152 filers reported holding AKERO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.85 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $87,370,517 | -3.6% | 2,419,425 | +24.7% | 2.91% | +11.1% |
| Q2 2023 | $90,610,116 | +352.4% | 1,940,675 | +270.7% | 2.62% | +343.8% |
| Q1 2023 | $20,030,067 | +4.3% | 523,525 | +49.4% | 0.59% | +9.6% |
| Q4 2022 | $19,208,770 | +31.2% | 350,525 | -18.5% | 0.54% | +26.8% |
| Q3 2022 | $14,642,000 | +2069.2% | 430,000 | +1860.1% | 0.42% | +4150.0% |
| Q3 2020 | $675,000 | – | 21,938 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 5,830,203 | $179,512,000 | 24.20% |
| venBio Partners LLC | 2,444,311 | $75,260,000 | 11.44% |
| Versant Venture Management, LLC | 777,727 | $23,946,000 | 4.38% |
| Redmile Group, LLC | 2,336,357 | $71,936,000 | 1.32% |
| Vivo Capital, LLC | 571,833 | $17,607,000 | 1.02% |
| Cormorant Asset Management, LP | 859,550 | $26,466,000 | 1.02% |
| Boxer Capital, LLC | 831,495 | $25,602,000 | 0.88% |
| Integral Health Asset Management, LLC | 85,000 | $2,617,000 | 0.80% |
| EAM Global Investors LLC | 49,718 | $1,531,000 | 0.56% |
| Crawford Lake Capital Management, LLC | 43,826 | $1,349,000 | 0.56% |